In last trading session, Pfizer Inc. (NYSE:PFE) saw 32.72 million shares changing hands with its beta currently measuring 0.61. Company’s recent per share price level of $26.34 trading at $0.02 or 0.08% at ring of the bell on the day assigns it a market valuation of $148.74B. That closing price of PFE’s stock is at a discount of -59.42% from its 52-week high price of $41.99 and is indicating a premium of 2.77% from its 52-week low price of $25.61. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 36.51 million shares which gives us an average trading volume of 43.15 million if we extend that period to 3-months.
Pfizer Inc. (NYSE:PFE) trade information
Upright in the green during last session for gaining 0.08%, in the last five days PFE remained trading in the red while hitting it’s week-highest on Tuesday, 04/09/24 when the stock touched $26.34 price level, adding 3.94% to its value on the day. Pfizer Inc.’s shares saw a change of -8.51% in year-to-date performance and have moved -1.16% in past 5-day. Pfizer Inc. (NYSE:PFE) showed a performance of -5.96% in past 30-days. Number of shares sold short was 65.0 million shares which calculate 1.4 days to cover the short interests.
Pfizer Inc. (PFE) estimates and forecasts
Statistics highlight that Pfizer Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -20.59% of value to its shares in past 6 months, showing an annual growth rate of 20.65% while that of industry is 4.00. Apart from that, the company came raising its revenue forecast for fiscal year 2024. The company is estimating its revenue growth to decrease by -60.20% in the current quarter and calculating -37.30% decrease in the next quarter. This year revenue growth is estimated to rise 2.60% from the last financial year’s standing.
13 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $12.98 billion for the same. And 13 analysts are in estimates of company making revenue of $12.14 billion in the next quarter that will end on Jun 2024. Company posted $16.59 billion and $12.73 billion of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to shrink by -21.80% while estimating it to be -4.70% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -27.43% during past 5 years. In 2024, company’s earnings growth rate is likely to be around 20.33% while estimates for its earnings growth in next 5 years are of -1.20%.
PFE Dividends
Pfizer Inc. is more likely to be releasing its next quarterly report on May 01 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
Pfizer Inc. (NYSE:PFE)’s Major holders
Insiders are in possession of 0.05% of company’s total shares while institution are holding 69.96 percent of that, with stock having share float percentage of 69.99%. Investors also watch the number of corporate investors in a company very closely, which is 69.96% institutions for Pfizer Inc. that are currently holding shares of the company. Vanguard Group Inc is the top institutional holder at PFE for having 508.09 million shares of worth $18.64 billion. And as of Jun 29, 2023, it was holding 9.00% of the company’s outstanding shares.
The second largest institutional holder is Blackrock Inc., which was holding about 445.15 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 7.88% of outstanding shares, having a total worth of $16.33 billion.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 176.05 million shares of worth $6.46 billion or 3.12% of the total outstanding shares. The later fund manager was in possession of 134.41 million shares on Jun 29, 2023, making its stake of worth around $4.93 billion in the company or a holder of 2.38% of company’s stock.
